Cytomegalovirus retinitis after central retinal vein occlusion in a patient on systemic immunosuppression: Does venooclusive disease predispose to cytomegalovirus retinitis in patients already at risk?

John D. Welling, Ahmad B. Tarabishy, John B Christoforidis

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cytomegalovirus (CMV) retinitis remains the most common opportunistic ocular infection in immunocompromised patients. Patients with immunocompromising diseases, such as acquired immunodeficiency syndrome, inherited immunodeficiency states, malignancies, and those on systemic immunosuppressive therapy, are known to be at risk. Recently, it has been suggested that patients undergoing intravitreal injection of immunosuppressive agents may also be predisposed. One previous case report speculated that there may be an additional risk for CMV retinitis in acquired immunodeficiency syndrome patients with venoocclusive disease. This case study presents a case of CMV retinitis following central retinal vein occlusion in a patient on systemic immunosuppressants.

Original languageEnglish (US)
Pages (from-to)601-603
Number of pages3
JournalClinical Ophthalmology
Volume6
Issue number1
DOIs
StatePublished - Apr 17 2012
Externally publishedYes

Fingerprint

Cytomegalovirus Retinitis
Retinal Vein
Retinal Vein Occlusion
Immunosuppression
Immunosuppressive Agents
Acquired Immunodeficiency Syndrome
Eye Infections
Intravitreal Injections
Opportunistic Infections
Immunocompromised Host
Neoplasms

Keywords

  • Central retinal vein occlusion
  • Cytomegalovirus retinitis
  • Immunosuppression
  • Risk factor
  • Solid organ transplant
  • Venous stasis

ASJC Scopus subject areas

  • Ophthalmology

Cite this

@article{02d5cc384e7f433b83cbfc0a2122da5e,
title = "Cytomegalovirus retinitis after central retinal vein occlusion in a patient on systemic immunosuppression: Does venooclusive disease predispose to cytomegalovirus retinitis in patients already at risk?",
abstract = "Cytomegalovirus (CMV) retinitis remains the most common opportunistic ocular infection in immunocompromised patients. Patients with immunocompromising diseases, such as acquired immunodeficiency syndrome, inherited immunodeficiency states, malignancies, and those on systemic immunosuppressive therapy, are known to be at risk. Recently, it has been suggested that patients undergoing intravitreal injection of immunosuppressive agents may also be predisposed. One previous case report speculated that there may be an additional risk for CMV retinitis in acquired immunodeficiency syndrome patients with venoocclusive disease. This case study presents a case of CMV retinitis following central retinal vein occlusion in a patient on systemic immunosuppressants.",
keywords = "Central retinal vein occlusion, Cytomegalovirus retinitis, Immunosuppression, Risk factor, Solid organ transplant, Venous stasis",
author = "Welling, {John D.} and Tarabishy, {Ahmad B.} and Christoforidis, {John B}",
year = "2012",
month = "4",
day = "17",
doi = "10.2147/OPTH.S28086",
language = "English (US)",
volume = "6",
pages = "601--603",
journal = "Clinical Ophthalmology",
issn = "1177-5467",
publisher = "Dove Medical Press Ltd.",
number = "1",

}

TY - JOUR

T1 - Cytomegalovirus retinitis after central retinal vein occlusion in a patient on systemic immunosuppression

T2 - Does venooclusive disease predispose to cytomegalovirus retinitis in patients already at risk?

AU - Welling, John D.

AU - Tarabishy, Ahmad B.

AU - Christoforidis, John B

PY - 2012/4/17

Y1 - 2012/4/17

N2 - Cytomegalovirus (CMV) retinitis remains the most common opportunistic ocular infection in immunocompromised patients. Patients with immunocompromising diseases, such as acquired immunodeficiency syndrome, inherited immunodeficiency states, malignancies, and those on systemic immunosuppressive therapy, are known to be at risk. Recently, it has been suggested that patients undergoing intravitreal injection of immunosuppressive agents may also be predisposed. One previous case report speculated that there may be an additional risk for CMV retinitis in acquired immunodeficiency syndrome patients with venoocclusive disease. This case study presents a case of CMV retinitis following central retinal vein occlusion in a patient on systemic immunosuppressants.

AB - Cytomegalovirus (CMV) retinitis remains the most common opportunistic ocular infection in immunocompromised patients. Patients with immunocompromising diseases, such as acquired immunodeficiency syndrome, inherited immunodeficiency states, malignancies, and those on systemic immunosuppressive therapy, are known to be at risk. Recently, it has been suggested that patients undergoing intravitreal injection of immunosuppressive agents may also be predisposed. One previous case report speculated that there may be an additional risk for CMV retinitis in acquired immunodeficiency syndrome patients with venoocclusive disease. This case study presents a case of CMV retinitis following central retinal vein occlusion in a patient on systemic immunosuppressants.

KW - Central retinal vein occlusion

KW - Cytomegalovirus retinitis

KW - Immunosuppression

KW - Risk factor

KW - Solid organ transplant

KW - Venous stasis

UR - http://www.scopus.com/inward/record.url?scp=84863457538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863457538&partnerID=8YFLogxK

U2 - 10.2147/OPTH.S28086

DO - 10.2147/OPTH.S28086

M3 - Article

C2 - 22570539

AN - SCOPUS:84863457538

VL - 6

SP - 601

EP - 603

JO - Clinical Ophthalmology

JF - Clinical Ophthalmology

SN - 1177-5467

IS - 1

ER -